BG103115A - Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety - Google Patents

Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Info

Publication number
BG103115A
BG103115A BG103115A BG10311599A BG103115A BG 103115 A BG103115 A BG 103115A BG 103115 A BG103115 A BG 103115A BG 10311599 A BG10311599 A BG 10311599A BG 103115 A BG103115 A BG 103115A
Authority
BG
Bulgaria
Prior art keywords
steroids
strimulators
syptoms
syndrom
neurochemical
Prior art date
Application number
BG103115A
Other languages
Bulgarian (bg)
English (en)
Inventor
Clive Jennings-White
David Berliner
Nathan Adams
Luis Bloch-Monti
Original Assignee
Pherin Pharmaceuticals, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,092 external-priority patent/US6057439A/en
Application filed by Pherin Pharmaceuticals, Inc filed Critical Pherin Pharmaceuticals, Inc
Publication of BG103115A publication Critical patent/BG103115A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BG103115A 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety BG103115A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/686,092 US6057439A (en) 1994-08-04 1996-07-23 Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US72586296A 1996-10-04 1996-10-04
PCT/US1997/013035 WO1998003207A1 (en) 1996-07-23 1997-07-23 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Publications (1)

Publication Number Publication Date
BG103115A true BG103115A (en) 1999-09-30

Family

ID=27103741

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103115A BG103115A (en) 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Country Status (15)

Country Link
EP (1) EP0914165B1 (de)
JP (1) JP4450435B2 (de)
KR (1) KR20000067970A (de)
CN (1) CN1226837A (de)
AT (1) ATE342721T1 (de)
AU (1) AU726625B2 (de)
BG (1) BG103115A (de)
BR (1) BR9711812A (de)
CA (1) CA2260253A1 (de)
DE (1) DE69736833T2 (de)
ES (1) ES2273374T3 (de)
NO (1) NO990305L (de)
NZ (1) NZ333671A (de)
PL (1) PL331357A1 (de)
WO (1) WO1998003207A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
US6555531B1 (en) 1999-12-30 2003-04-29 Pherin Pharmaceuticals, Inc. Weight promoting composition, method, and product
US8309539B2 (en) 2005-09-09 2012-11-13 Pherin Pharmaceuticals, Inc. Acute treatment of social phobia
EP2278880B1 (de) * 2008-04-09 2012-10-10 Pherin Pharmaceuticals, Inc. Steroidbehandlung für hitzewallungen
WO2014105620A1 (en) * 2012-12-28 2014-07-03 Pherin Pharmaceuticals, Inc. Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders
DK3955933T3 (da) * 2019-04-15 2024-02-12 Vistagen Therapeutics Inc Behandling af migræne
US20220396597A1 (en) * 2019-10-25 2022-12-15 Washington University Nmdar inhibiting agents and gabaar potentiating agents and uses thereof
CN112608358A (zh) * 2020-12-29 2021-04-06 北京大学 一种促进花粉萌发的化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
HUT74171A (en) * 1993-06-15 1996-11-28 Pherin Corp Estrene steroids as neurochemical initiators of change in human hypothalamic function and pharmaceutical compositions containing them
CA2165325A1 (en) * 1993-06-15 1994-12-22 David L. Berliner Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
JPH10509423A (ja) * 1994-09-29 1998-09-14 フェリン コーポレイション 視床下部作用を誘起する新規なエストレン類
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Also Published As

Publication number Publication date
EP0914165B1 (de) 2006-10-18
CN1226837A (zh) 1999-08-25
NZ333671A (en) 2000-07-28
WO1998003207A1 (en) 1998-01-29
AU726625B2 (en) 2000-11-16
JP2000513000A (ja) 2000-10-03
PL331357A1 (en) 1999-07-05
JP4450435B2 (ja) 2010-04-14
NO990305D0 (no) 1999-01-22
AU3963797A (en) 1998-02-10
KR20000067970A (ko) 2000-11-25
ES2273374T3 (es) 2007-05-01
CA2260253A1 (en) 1998-01-29
DE69736833T2 (de) 2007-05-24
BR9711812A (pt) 1999-08-24
NO990305L (no) 1999-03-22
ATE342721T1 (de) 2006-11-15
DE69736833D1 (de) 2006-11-30
EP0914165A4 (de) 2004-01-21
EP0914165A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
PL339295A1 (en) Novel application of budesonide and formotherol
ATE241337T1 (de) Hautpflegemittel für gealterte haut
DE69432990D1 (de) PROGESTAGEN-FREIE FORMULIERUNGEN VON GnRH UND ESTROGEN ZUR BEHANDLUNG VON BENIGNEN GYNÄKOLOGISCHEN STÖRUNGEN
EP0870786A4 (de) Dienkautschuk verfahren zu dessen herstellung und diesen kautschuk enthaltende zusammensetzung
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
PL324970A1 (en) Method of and composition for treating asthma
DE69329240D1 (de) 17-ether und thioether von 4-aza-steroiden
DE69722223D1 (de) Textilweichspülmittelzusammensetzung und anwendungsmethode für die freisetzung von riechstoffderivaten
CA2289531A1 (en) Composition and methods for treating alzheimer's disease and other amyloidoses
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
CA2069483A1 (en) Steroid sulphatase inhibitors
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
EP0761239A4 (de) Desodorierendes verfahren, deodorant, verfahren zur deodorantherstellung und desodorierende ausstattung
GR3036710T3 (en) Monofunctional and/or polyfunctional polylysine conjugates
HUP0000622A3 (en) Antiperspirant or deodorant composition and process for producing thereof
BG103170A (en) Polymorphic form ii of finasteride and method for its preparation
HUP0002716A3 (en) Perfumed one and two phase compositions for reducing body odor and methods of use thereof
AU4584901A (en) Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
DE69722484D1 (de) Präparat für Aerosol-Antitranspirant und Verfahren zur Herstellung
HUP0000642A3 (en) Antiperspirant or deodorant composition and process for producing thereof
BG103060A (bg) 19- нор- холан стероиди като неврохимични инициатори на промяната в действието на хипоталамуса причовек
CA2232433A1 (fr) Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux
EP0810882A4 (de) Verfahren und zusammensetzung für die regulation der cd28-expression
PL329387A1 (en) Novel steroids, their application as medical agents, method of obtaining them, intermediate compounds appearing in the process of obtaining them and compositions containing such novel steroids